| Pharmaceutical active ingredients: |
| Ondansetron |
| Available forms, composition and doses of Ondansetron: |
| Tablets, Film-Coated; Oral; Ondansetron 4 mgTablets, Film-Coated; Oral; Ondansetron 8 mg |
| Ondansetron medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Okasa Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ondansetron | Ondansetron Hydrochloride | Mylan |
| Ondansetron | Ondansetron Hydrochloride | Natco Pharma |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Novopharm |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Novosibkhimfarm |
| Ondansetron | Ondansetron Hydrochloride | Odan Laboratories |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Omega Laboratories |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Pharma Strides Canada Corporation |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Pharmaceutical Partners of Canada |
| Ondansetron | Ondansetron Hydrochloride | PharmaForce |
| Ondansetron | Ondansetron Hydrochloride | Pliva |